SCHEMBL14830555

SCHEMBL14830555

O=C1C(=O)N(c2ccc(I)cc2)c2ccccc21

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 8/20 0.73
BCHE P06276 3/20 0.73
ALDH1A1 P00352 2/20 0.73
CES2 O00748 1/20 0.73
GAA P10253 1/20 0.73
NPSR1 Q6W5P4 1/20 0.73
TTR P02766 1/20 0.47
AOC3 Q16853 2/20 0.47
TGM2 P21980 1/20 0.46
FAAH O00519 1/20 0.46
MGLL Q99685 1/20 0.46
AGTR1 P30556 1/20 0.43
PDE6D O43924 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
SCN2A Q99250 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenyl Isatin SCHEMBL916808 0.85 CES1 (1.00) CES1BCHEALDH1A1CES2GAA
SCHEMBL2305737 0.82 CES1 (0.73) CES1BCHEALDH1A1CES2GAA
SCHEMBL30951976 0.82 CES1 (0.73) CES1BCHEALDH1A1CES2GAA
SCHEMBL5352173 0.82 CES1 (0.73) CES1BCHEALDH1A1CES2GAA
SCHEMBL14830299 0.82 CES1 (0.73) CES1BCHEALDH1A1CES2GAA
SCHEMBL20721761 0.82 CES1 (0.73) CES1BCHEALDH1A1CES2GAA
SCHEMBL29506688 0.82 CES1 (0.73) CES1BCHEALDH1A1CES2GAA
SCHEMBL10748810 0.79 KMT2A (0.64) ALDH1A1GAAFAAHMGLLMEN1
SCHEMBL7448157 0.79 MGLL (0.43) CES1BCHEALDH1A1CES2GAA
SCHEMBL2348974 0.79 CES1 (0.73) CES1BCHEALDH1A1CES2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023067628-A1 A METHOD FOR THE PREPARATION OF INDOLE-3-CARBOXYLIC ACID DERIVATIVES COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860) (IN) 2023-04-27 WO disclosed
EP-2760840-B1 QUINOLINONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE BRISTOL MYERS SQUIBB CO (US) 2015-08-12 EP disclosed
US-20150105376-A1 QUINOLINONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE BRISTOL MYERS SQUIBB CO (US) 2015-04-16 US disclosed
US-8946430-B2 Quinolinone carboxamide inhibitors of endothelial lipase BRISTOL-MYERS SQUIBB COMPANY (US) 2015-02-03 US disclosed
US-20140243314-A1 QUINOLINONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE BRISTOL-MYERS SQUIBB COMPANY 2014-08-28 US disclosed
EP-2760840-A1 QUINOLINONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE Bristol-Myers Squibb Company (US) 2014-08-06 EP disclosed
WO-2013048942-A1 QUINOLINONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE BRISTOL-MYERS SQUIBB COMPANY (US) 2013-04-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150105376-A1 QUINOLINONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE LIPG, PNLIP, LPL CES1 9/4885BCHE 199/4885ALDH1A1 440/4885
US-20140243314-A1 QUINOLINONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE LIPG, PNLIP, LPL CES1 9/4885BCHE 199/4885ALDH1A1 440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.